Emerging Diseases News

A single dose of a typhoid conjugate vaccine provided protection for at least 4 years among children aged 9 months to 12 years enrolled in a phase 3 trial in Malawi, according to results published in The Lancet.

Risks for adverse outcomes associated with COVID-19 at delivery stayed high during the omicron variant window, despite possible immunity from previous SARS-CoV-2 infection, vaccination or testing differences, researchers reported.

A national survey of ID fellowship program directors revealed that only about a third of programs have a dedicated infection prevention and control and health care epidemiology training track.

Three or more doses of maternal COVID-19 vaccine significantly enhance antibody concentrations in preterm infants compared with two or fewer doses, according to study results published in JAMA Network Open.

Wastewater surveillance can detect a single mpox case in large samples representing thousands to millions of people, and its effectiveness increases as the number of cases grows, according to a study.

COVID-19 vaccination reduces the risk for long COVID in children, according to findings from a study of more than 1 million children published in Pediatrics.

Treating infants with azithromycin at well-child visits did not reduce mortality during a yearslong study in Burkina Faso, according to findings published Wednesday in The New England Journal of Medicine.

Nearly one in five patients diagnosed with multisystem inflammatory syndrome in children based on a 2020 definition would not be diagnosed with the illness using an updated definition, researchers reported in Pediatrics.

Paxlovid did not reduce the risk for long COVID among vaccinated, nonhospitalized people who received it within a month of their first SARS-CoV-2 infection, a study showed.

During a 2022 mpox outbreak in a Nigerian tertiary care facility, several confirmed cases presented atypically, according to a recent assessment of cases.